Back to Search
Start Over
Expression of the human isoform of glutamate dehydrogenase, hGDH2, augments TCA cycle capacity and oxidative metabolism of glutamate during glucose deprivation in astrocytes.
- Source :
-
Glia [Glia] 2017 Mar; Vol. 65 (3), pp. 474-488. Date of Electronic Publication: 2016 Dec 29. - Publication Year :
- 2017
-
Abstract
- A key enzyme in brain glutamate homeostasis is glutamate dehydrogenase (GDH) which links carbohydrate and amino acid metabolism mediating glutamate degradation to CO <subscript>2</subscript> and expanding tricarboxylic acid (TCA) cycle capacity with intermediates, i.e. anaplerosis. Humans express two GDH isoforms, GDH1 and 2, whereas most other mammals express only GDH1. hGDH1 is widely expressed in human brain while hGDH2 is confined to astrocytes. The two isoforms display different enzymatic properties and the nature of these supports that hGDH2 expression in astrocytes potentially increases glutamate oxidation and supports the TCA cycle during energy-demanding processes such as high intensity glutamatergic signaling. However, little is known about how expression of hGDH2 affects the handling of glutamate and TCA cycle metabolism in astrocytes. Therefore, we cultured astrocytes from cerebral cortical tissue of hGDH2-expressing transgenic mice. We measured glutamate uptake and metabolism using [ <superscript>3</superscript> H]glutamate, while the effect on metabolic pathways of glutamate and glucose was evaluated by use of <superscript>13</superscript> C and <superscript>14</superscript> C substrates and analysis by mass spectrometry and determination of radioactively labeled metabolites including CO <subscript>2</subscript> , respectively. We conclude that hGDH2 expression increases capacity for uptake and oxidative metabolism of glutamate, particularly during increased workload and aglycemia. Additionally, hGDH2 expression increased utilization of branched-chain amino acids (BCAA) during aglycemia and caused a general decrease in oxidative glucose metabolism. We speculate, that expression of hGDH2 allows astrocytes to spare glucose and utilize BCAAs during substrate shortages. These findings support the proposed role of hGDH2 in astrocytes as an important fail-safe during situations of intense glutamatergic activity. GLIA 2017;65:474-488.<br /> (© 2016 Wiley Periodicals, Inc.)
- Subjects :
- Animals
Astrocytes drug effects
Carbon Dioxide pharmacokinetics
Carbon Isotopes pharmacokinetics
Cells, Cultured
Cerebral Cortex cytology
Citric Acid Cycle drug effects
Citric Acid Cycle genetics
Dose-Response Relationship, Drug
Glial Fibrillary Acidic Protein metabolism
Glutamate Dehydrogenase genetics
Glutamic Acid pharmacology
Humans
Mice
Mice, Inbred C57BL
Mice, Transgenic
Protein Isoforms genetics
Protein Isoforms metabolism
Sugar Alcohol Dehydrogenases metabolism
Tritium pharmacokinetics
Astrocytes metabolism
Citric Acid Cycle physiology
Gene Expression Regulation, Enzymologic
Glucose deficiency
Glutamate Dehydrogenase metabolism
Glutamic Acid metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1098-1136
- Volume :
- 65
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Glia
- Publication Type :
- Academic Journal
- Accession number :
- 28032919
- Full Text :
- https://doi.org/10.1002/glia.23105